Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Jade Biosciences

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences Announces $135 Million Private Placement
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences to Participate in Upcoming Conferences
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences to Participate in Two Upcoming Investor Conferences
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
From Jade Biosciences
Via GlobeNewswire
Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit
From Jade Biosciences
Via GlobeNewswire
Jade Biosciences to Participate in Upcoming Investor Conferences
From Jade Biosciences
Via GlobeNewswire
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement
From Jade Biosciences
Via GlobeNewswire
Tickers AVTE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.